ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
720	Centers for Disease Control and Prevention	Html	en	World AIDS Day - December 1, 2013	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	mmwrq@cdc.gov. 0.66474 Human Services 0.90694 assistive technology 0.668078 Joint United Nations 0.999607 U.S. Department 0.758546 MMWR HTML versions 0.75543 AIDS Relief 0.653205 electronic PDF version 0.741115 global AIDS epidemic 0.783027 Emergency Plan 0.648279 Global report 0.654469 middle-income countries 0.657683 epidemic worldwide 0.666742 Contact GPO 0.661343 commercial sources 0.638634 World AIDS 0.668071 current prices 0.637986 persons 0.650156 U.S. dependent areas—2010 0.774847 original paper copy 0.747041 surveillance supplemental report 0.778527 Global efforts 0.64405 care objectives 0.638263 human immunodeficiency 0.686309	Shared Responsibility 0.650596 AIDS diagnoses 0.663741 United States 0.652498 CDC. Monitoring 0.643379 U.S. Government Printing 0.762265 original MMWR paper 0.751126 antiretroviral therapy 0.657418 U.S. President 0.652887 Strengthening Results 0.653727 MMWR readers 0.647878 character translation 0.632646 HIV surveillance report 0.845521 national HIV prevention 0.821851 immunodeficiency syndrome 0.678829 HIV surveillance 0.925813 format errors 0.632221 current status 0.658365 UNAIDS report 0.706724 United Nations Programme 0.999496 subject line 0.664734 typeset documents 0.638732 trade names 0.638727 non-CDC sites 0.636909 AIDS-Free Generation 0.653864	CLICK HERE
1011	Centers for Disease Control and Prevention	Html	en	Announcement: Updated Guidelines on Managing DrugInteractions in the Treatment of HIV-Related Tuberculosis	Guidelines for managing pharmacologic interactions that can result when patients receive antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection together with rifamycin antibiotics for treatment of tuberculosis (TB) have been published previously (1–4). Newly updated guidelines, developed by CDC in collaboration with experts from other key national and international institutions, are now available at http://www.cdc.	latent TB infection 0.797716 online guidelines 0.583453 pharmacokinetic data 0.582676 endorsement 0.485791 additional recommendations 0.58107 Human Services 0.705094 latest information 0.563705 U.S. Department 0.70552 MMWR HTML versions 0.691045 Newly updated guidelines 0.764533 pregnant women 0.566426 electronic PDF version 0.676732 special populations 0.564704 young children 0.565898 integrase inhibitors 0.57837 Contact GPO 0.590737 patients 0.456114 commercial sources 0.562289 current prices 0.553473 new classes 0.576329 specific antiretroviral regimens 0.938608 original paper copy 0.671566 clinical experience 0.685522 human immunodeficiency virus 0.753453	antiretroviral drugs 0.910693 drug-resistant TB 0.664991 pharmacologic interactions 0.596 new guidelines 0.594589 antiretroviral therapy 0.727316 original MMWR paper 0.683987 U.S. Government Printing 0.675466 rifabutin 0.444818 international institutions 0.583989 MMWR readers 0.568012 character translation 0.552373 newer antiretroviral drugs 0.879481 format errors 0.55579 TB treatment 0.658395 rifamycin antibiotics 0.591771 New features 0.572378 Health 0.450891 typeset documents 0.562811 trade names 0.562424 official text 0.550056 CCR5 receptor antagonists 0.741922 non-CDC sites 0.55996 key antiretroviral regimens 0.935141 electronic conversions 0.550725	CLICK HERE
5440	Centers for Disease Control and Prevention	Html	en	Dichlorodifluoromethane - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
5813	Centers for Disease Control and Prevention	Html	en	Lead - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
5838	Centers for Disease Control and Prevention	Html	en	Mica (containing less than 1% quartz) - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
7217	Centers for Disease Control and Prevention	Html	en	Preconception Care - Articles and Documents	null	Mortality Weekly Report 0.434574 Select Panel 0.306918 Health Care Clinical 0.373492 National Summit 0.264444 Health Issues 0.308562 Action Plan 0.262559 Disease Control 0.262361 Consumer Workgroup Meetings 0.309896 technical materials 0.277872 Family Physician 0.264928 Lauren B. Zapata 0.331851 American Board 0.265793 American Journal 0.323136 comprehensive database 0.275129 Interconception Health Status 0.36365 Pages S1-S126 0.266927 preconception care 0.84139 National Preconception Health 0.586329 Preconception Health Agenda 0.632998 Child Health Journal 0.362226 Behavioral Risk Factor 0.333305 preconception-related publications 0.276382 Financing Issues 0.267162 Essential Role 0.262303	United States 0.327352 Gynecologic Practice 0.26515 Reporting Areas 0.26627 Live-Born Infant 0.264867 Pregnancy Risk Assessment 0.451765 Cheryl L. Robbins 0.327549 preconception health 0.957222 National Library 0.28104 Special Issue 0.263629 health care 0.548658 public health 0.32494 PubMed service 0.275615 National Initiative 0.267273 Sherry L. Farr 0.330397 Dunlop AL 0.269772 State Preconception Health 0.667386 Health Care Initiative 0.377255 Family Medicine 0.26414 Clinical Content 0.269846 et al 0.396218 Women’s Health 0.316499 Risk Assessment Monitoring 0.451715 Health Care Summary 0.374235 National Recommendations 0.293547	CLICK HERE
10939	Centers for Disease Control and Prevention	Html	en	Should I Get Screened for Prostate Cancer?	CDC and other federal agencies follow the prostate cancer screening recommendations set forth by the U.S. Preventive Services Task Force, which recommends against PSA-based screening for men who do not have symptoms.	abnormal results 0.764558 prostate cells 0.647202 infection 0.431069 CDC 0.490571 bleeding 0.436471 Force 0.434412 Physicians 0.431815 false negative results 0.725839 abnormal result 0.611705 recommendations 0.477829 right decision 0.578356 American Cancer Society 0.722577 men 0.534685 American Urological Association 0.735629 federal agencies 0.59959 Preventive Services Task 0.76553	tissues 0.436748 minor surgery 0.563017 prostate specific antigen 0.876325 man— 0.428735 -based screening 0.639876 symptoms 0.434101 anxiety 0.432142 prostate cancer 0.953809 PSA test 0.955098 theU.S 0.434784 tests 0.430299 doctors 0.429044 decision making 0.696349 organizations 0.432077 College 0.431846	CLICK HERE
15495	Centers for Disease Control and Prevention	Html	en	Youth Risk Behavior Surveillance - United States, 2015 | MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	11th-grade female 0.289414 data 0.270606 standard questionnaire 0.272894 12th-grade male 0.358019 school district surveys 0.300832 priority health behaviors 0.287405 urban school districts 0.737908 Youth Risk Behavior 0.350811 school property 0.408176 10th-grade male 0.324657 health behaviors 0.320187 Hispanic male 0.341259 9th-grade male 0.318679 bicycle helmet 0.283184 white female 0.284716 Hispanic female 0.295549 median 0.285032 survey 0.31385 long-term temporal trends 0.269469 school district youth 0.250437 significant quadratic trend 0.425522 male 0.482363 large urban school 0.916678 United States 0.280258 students 0.741386	11th-grade male 0.337941 white male 0.372075 states 0.329048 prevalence estimates 0.271133 response options 0.250217 prevalence 0.544116 Hispanic students 0.25877 10th-grade female 0.282971 urban school district 0.466051 significant linear decrease 0.37032 private¶ school students 0.25137 Table 0.296649 national YRBS 0.331635 response rates 0.256072 national YRBS prevalence 0.258931 high school students 0.321955 safety concerns 0.279745 black male 0.350527 physical fight 0.394458 black female 0.277334 seat belt 0.258479 12th-grade female 0.345099 school enrollment size 0.256959 Risk Behavior Surveillance 0.283509	CLICK HERE
16090	Centers for Disease Control and Prevention	Html	en	What Health Care Providers Need to Know about PDMPs	null	effective pain management 0.785602 abuse 0.434805 patients 0.461101 history 0.434927 people 0.434964 electronic database 0.64532 way opioids 0.733023 prescription drug monitoring 0.968327	Clinical practice guidelines 0.792341 number 0.435043 prescription drugs 0.736751 patient 0.435004 prescription opioids 0.852481 risk 0.436641 PDMPs 0.437435	CLICK HERE
16244	Centers for Disease Control and Prevention	Html	en	Notes from the Field: Community-Based Prevention of RockyMountain Spotted Fever - Sonora, Mexico, 2016 | MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	1Epidemic Intelligence Service 0.459287 highly affected communities 0.482052 high rates 0.411352 CDC 0.412725 original MMWR paper 0.46499 community leaders 0.428263 U.S. national average 0.492209 multisystem organ failure 0.488969 life-threatening tickborne zoonosis 0.504854 public health veterinarians 0.489682 Human Services 0.465603 2Rickettsial Zoonoses Branch 0.459138 human disease cases 0.502263 tick populations 0.440694 human exposure 0.410671 Sonora MOH 0.904649 Rh. sanguineus ticks 0.507946 massive local infestations 0.501266 U.S. Department 0.467013 timely administration 0.413065 Rhipicephalus-associated RMSF 0.488143 human RMSF cases 0.541715 RMSF deaths 0.43969 electronic PDF version 0.460106	health services 0.4236 intervention area 0.454912 case fatality rates 0.481753 Zoonotic Infectious Diseases 0.45607 adjacent yard areas 0.459193 MOH vector-control operators 0.536011 severe RMSF 0.43669 domestic dogs 0.504399 visible tick infestations 0.51884 RMSF transmission 0.421105 long-acting tick collars 0.535434 community B. 0.421641 northern Mexico 0.422235 health messages 0.411181 RMSF 0.546064 unpublished data 0.471973 Epidemic RMSF 0.451344 timely pesticide application 0.468261 case-fatality rate 0.55705 R. rickettsii 0.423395 aggregate case-fatality rate 0.473345 local health care 0.493933 Mexico Ministry 0.422544	CLICK HERE